FDA Accepts Amgen's Biosimilar Biologics License Application For ABP 501
January 25, 2016 at 17:21 PM EST
Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Amgen's Biologics License ...